Différences
Ci-dessous, les différences entre deux révisions de la page.
| Les deux révisions précédentes Révision précédente | |||
|
acupuncture:evaluation:neuro-psychiatrie:07. depression post-avc [17 Oct 2025 13:18] Nguyen Johan [1.2.1.1. Wang 2021] |
acupuncture:evaluation:neuro-psychiatrie:07. depression post-avc [17 Oct 2025 13:23] (Version actuelle) Nguyen Johan [2.1. Meng 2025] |
||
|---|---|---|---|
| Ligne 309: | Ligne 309: | ||
| ===== Overviews of Systematic Reviews ===== | ===== Overviews of Systematic Reviews ===== | ||
| + | |||
| + | |||
| + | ==== Liu 2025 ==== | ||
| + | |||
| + | |||
| + | Liu X, Zhu F, Zhang JL, He ZX, Yin S, Wu RH, He YY, Zeng F. Effectiveness and Safety of Acupuncture as an Adjunctive Therapy for Post-Stroke Depression: An Overview of Systematic Reviews. Neuropsychiatr Dis Treat. 2025 Aug 1;21:1569–1588. https://doi.org/10.2147/NDT.S526413 | ||
| + | |||
| + | ^Background|Post-stroke depression (PSD) is a common and serious neuropsychiatric complication that requires effective treatment options. Acupuncture as an adjuvant therapy shows promise, though current systematic reviews exhibit significant discrepancies in effectiveness and safety evidence, with insufficient methodological rigor. The objective was to evaluate systematic reviews assessing acupuncture as an adjuvant therapy for PSD.| | ||
| + | ^Methods|Eight databases were searched from inception to March 2024 using terms such as “acupuncture and moxibustion therapy”, “post-stroke depression”, and “systematic evaluation”. All systematic reviews underwent methodological evaluation with four tools: AMSTAR 2 for methodological quality, ROBIS for risk of bias, PRISMA 2020 for reporting standards, and GRADE for evidence grading. Inter-reviewer consistency was measured using the k-index.| | ||
| + | ^Results|**Ten systematic reviews** were included. According to AMSTAR 2, 9 of 10 (90%) were rated as “very low” confidence. Based on ROBIS, only 3 reviews (30%) had a low risk of bias. Reporting quality met PRISMA 2020 standards overall, but evidence grading was insufficient in most cases (only 2/10 adequately assessed). Using GRADE, 58.8% (20/34 outcomes) were rated “very low”. Acupuncture as an adjunctive therapy combined with conventional treatments significantly improved HAMD and NIHSS scores compared with monotherapy.| | ||
| + | ^Conclusion|Acupuncture as an adjunctive therapy appears to improve depressive symptoms and functional outcomes in PSD, but the generally low methodological quality and inconsistent evidence limit the reliability of these conclusions. Further high-quality, rigorously designed systematic reviews and trials are needed.| | ||
| + | |||
| ==== Meng 2025 ==== | ==== Meng 2025 ==== | ||
